abstract |
The invention relates to the field of apoptosis. Theninvention provides novel therapeutic substances, for examplennovel therapeutic proteinaceous compounds that can containnapoptin alone or jointly with other proteinaceous protein ornprotein fragments, especially in those cases when cells arenderailed such as cancer-, auto-immune-derived cells. |